Clinical Trial Update: Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis [Phase 4]

View source ↗

Summary

This Phase 4 trial update notes the completion of a four-week safety and efficacy pilot study of AzaSite for blepharitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Blepharitis | Phase 4 | Status: COMPLETED